Table 2.

Characteristic of patients suffering a stroke.

	All	IS	HS	p
Time from TAVR (months)	20.6 (9.9–38.3)	19.7 (9.7–37.3)	30.0 (10.0–44.4)	0.253
Age	83.8 (7.5)	84.1 (7.5)	81.5 (7.5)
Male sex	125 (54.8%)	107 (52.7%)	17 (70.8%)	0.092
Hospitalization total (days)	14.2 (13.2)	14.4 (13.5)	13.0 (10.3)	0.886
TIA/Amaurosis Fugax	27 (11.9%)	24 (11.9%)	3 (13.0%)	0.871
Previous stroke	54 (23.8%)	48 (23.8%)	6 (25.0%)	0.893
Atrial fibrillation	112 (47.7%)	98 (46.7%)	13 (54.2%)	0.486
Hypertension	174 (77.3%)	159 (79.1%)	14 (60.9%)	0.048
Diabetes	81 (35.8%)	69 (34.2%)	11 (47.8%)	0.194
On lipids	114 (50.4%)	103 (51.2%)	10 (41.7%)	0.375
On ASA	107 (47.3%)	100 (49.8%)	7 (29.2%)	0.056
On clopidrogel	35 (15.5%)	32 (15.9%)	3 (12.5%)	0.662
On antihypertensives	183 (88.4%)	165 (90.2%)	17 (73.9%)	0.022
On OAC/NOAC	53 (23.5%)	45 (22.4%)	8 (33.3%)	0.232
Consciousness at arrival
Awake	193 (82.1%)	178 (84.8%)	14 (58.3%)	< 0.001
Reduced consciousness	19 (8.1%)	15 (7.1%)	4 (16.7%)
Unconscious	12 (5.1%)	7 (3.3%)	6(25.0%)
Unknown	11 (4.7%)	11 (5.2%)	0 (0.0%)
CT performed	225 (99.1%)	200 (99.0%)	24 (100.0%)	0.624
MRI performed	15 (6.6%)	14 (6.9%)	1 (4.2%)	0.607
Thrombolysis	12 (5.3%)	12 (6.0%)	0 (0.0%)
Thrombectomy	5 (2.4%)	5 (2.5%)	0 (0.0%)	0.631
Discharged to
Nursing home	46 (19.6%)	39 (18.6%)	7 (29.2%)	0.001
Home	93 (39.6%)	90 (42.9%)	3 (12.5%)
Rehab	35 (14.9%)	32 (15.2%)	2(12.3%)
Other facility	25 (10.6%)	24 (11.4%)	0 (0%)
Died	36 (15.3%)	25 (11.9%)	10 (41.7%)
30-day mortality	46 (19.6%)	34 (16.2%)	11 (45.8%)	< 0.001
1-year mortality	93 (44.1%)	79 (41.8%)	13 (61.9%)	0.167
3-year mortality	123 (67.3%)	108 (66.2%)	14 (74.6%)	0.521
5-year mortality	133 (81.7%)	117 (80.5%)	n/a

IS Ischemic stroke, HS haemorrhagic stroke, TAVR transcatheter aortic valve replacement, TIA transient ischemic attack, ASA acetylsalicylic acid, (N) OAC (NEW) oral anticoagulation, CT computed tomography, MRI magnetic resonance imaging.